Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV INFECTION”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05342337
What this trial is testing

Exercise Therapy With Telerehabilitation in Patients Living With HIV

Who this might be right for
HIV Infections
Hasan Kalyoncu University 55
Not applicableStudy completedNCT00014937
What this trial is testing

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Large-scale testing (Phase 3)Study completedNCT00002429
What this trial is testing

Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

Who this might be right for
HIV Infections
Bristol-Myers Squibb 500
Early research (Phase 1)Study completedNCT01231529
What this trial is testing

GSK1349572 Hepatic Impairment Study

Who this might be right for
Healthy SubjectsHepatic ImpairmentInfection, Human Immunodeficiency Virus+1 more
ViiV Healthcare 16
Not applicableStudy completedNCT03284645
What this trial is testing

Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids

Who this might be right for
Human Immunodeficiency Virus Infection
Obafemi Awolowo University 194
Post-approval studies (Phase 4)Study completedNCT04531072
What this trial is testing

Effect of Atazanavir-ritonavir on the Pharmacokinetics and Toxicity of Lumefantrine

Who this might be right for
Drug Interaction
Fogarty International Center of the National Institute of Health 20
Not applicableUnknownNCT00889395
What this trial is testing

Cognitive and Psychosocial Benefits of MISC Training for Ugandan Children

Who this might be right for
HIVHIV Infections
Makerere University 120
Not applicableStudy completedNCT02925429
What this trial is testing

PostNAPS: FI, Nutrition, and Psychosocial Health Among Women of Mixed HIV Status and Their Infants in Gulu, Uganda

Who this might be right for
Food InsecurityHIVMaternal and Child Health+2 more
Northwestern University 246
Not applicableStudy completedNCT02053129
What this trial is testing

Evaluation of PTB Screening in ANC in Lusaka, Zambia

Who this might be right for
Pulmonary Tuberculosis
University of North Carolina, Chapel Hill 5,033
Not applicableStudy completedNCT00342602
What this trial is testing

Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency Syndrome

Who this might be right for
PMLAIDS
National Cancer Institute (NCI) 450
Not applicableNot Yet RecruitingNCT07804602
What this trial is testing

PositiveLinks for Youth (PL4Y) for Texas

Who this might be right for
Human Immunodeficiency VirusHIV
The University of Texas Health Science Center at San Antonio 600
Not applicableStudy completedNCT03079856
What this trial is testing

Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER

Who this might be right for
Drug UseSex Behavior
University of Michigan 63
Large-scale testing (Phase 3)Study completedNCT00001022
What this trial is testing

A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Not applicableNot Yet RecruitingNCT06487351
What this trial is testing

Intervention to Reduce Implicit Bias in Pharmacies

Who this might be right for
Bias, ImplicitHIVPre-exposure Prophylaxis
Massachusetts General Hospital 70
Early research (Phase 1)Ended earlyNCT02531295
What this trial is testing

Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study

Who this might be right for
HIVHuman Immunodeficiency Virus
University of California, San Francisco 5
Not applicableUnknownNCT01525134
What this trial is testing

Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of Tuberculosis

Who this might be right for
TuberculosisTuberculosis, PulmonaryTuberculosis, Miliary
Tuberculosis Clinical Diagnostics Research Consortium 504
Post-approval studies (Phase 4)Study completedNCT00795717
What this trial is testing

Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial

Who this might be right for
Cardiovascular DiseaseHIV Infection
Tufts University 41
Not applicableStudy completedNCT04677374
What this trial is testing

Uptake of Medical Male Circumcision Among Men With Sexually Transmitted Infections

Who this might be right for
HIV InfectionsSexually Transmitted Infections
University of North Carolina, Chapel Hill 2,242
Not applicableStudy completedNCT04810559
What this trial is testing

Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood

Who this might be right for
HIV TestingHIV Infections
Unity Health Toronto 600
Testing effectiveness (Phase 2)Study completedNCT00002079
What this trial is testing

Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)

Who this might be right for
HIV Infections
G D Searle
Next Page